Patient Preference for Dosing Regimen and Perception of Dosing Flexibility With Fremanezumab for Migraine: Results From a Patient Survey Following Completion of a 1-Year Extension Study Cowan, R. P., Gandhi, S. K., Cloud, B., Cohen, J. M., Buse, D. C., Ramirez-Campos, V., Ahn, A. H., Lipton, R. B. LIPPINCOTT WILLIAMS & WILKINS. 2020

View details for Web of Science ID 000536058006269